MADRIGAL PHARMACEUTICALS, INC. Return On Equity in % from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Madrigal Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to Q3 2025.
  • Madrigal Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2025 was -41.5 %, a 42.2% increase year-over-year.
  • Madrigal Pharmaceuticals, Inc. annual Return On Equity for 2024 was -57.5 %, a 73.8% increase from 2023.
  • Madrigal Pharmaceuticals, Inc. annual Return On Equity for 2023 was -219 %, a 18.8% increase from 2022.
  • Madrigal Pharmaceuticals, Inc. annual Return On Equity for 2022 was -270 %, a 169% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -41.5 +30.3 +42.2% Jul 1, 2025 Sep 30, 2025
Q2 2025 -38.4 +57.2 +59.9% Apr 1, 2025 Jun 30, 2025
Q1 2025 -50.5 +78.1 +60.7% Jan 1, 2025 Mar 31, 2025
Q4 2024 -57.5 +162 +73.8% Oct 1, 2024 Dec 31, 2024
Q3 2024 -71.8 +222 +75.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -95.6 +190 +66.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -129 +156 +54.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -219 +50.8 +18.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -294 -42.2 -16.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -286 -131 -84.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -285 -168 -145% Jan 1, 2023 Mar 31, 2023
Q4 2022 -270 -170 -169% Oct 1, 2022 Dec 31, 2022
Q3 2022 -251 -157 -167% Jul 1, 2022 Sep 30, 2022
Q2 2022 -155 -67.8 -77.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -117 -39.3 -50.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -101 -36.2 -56.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -94 -46.4 -97.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -87.2 -53.3 -157% Apr 1, 2021 Jun 30, 2021
Q1 2021 -77.2 -52.5 -212% Jan 1, 2021 Mar 31, 2021
Q4 2020 -64.3 -45.5 -241% Oct 1, 2020 Dec 31, 2020
Q3 2020 -47.6 -33 -224% Jul 1, 2020 Sep 30, 2020
Q2 2020 -33.9 -22.3 -192% Apr 1, 2020 Jun 30, 2020
Q1 2020 -24.7 -16 -185% Jan 1, 2020 Mar 31, 2020
Q4 2019 -18.8 -10.8 -133% Oct 2, 2019 Dec 31, 2019
Q3 2019 -14.7 -5.72 -63.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -11.6 +1.55 +11.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -8.68 +17.8 +67.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -8.09 +29.4 +78.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -8.97 Jul 1, 2018 Sep 30, 2018
Q2 2018 -13.2 Apr 1, 2018 Jun 30, 2018
Q1 2018 -26.5 Jan 1, 2018 Mar 31, 2018
Q4 2017 -37.5 Oct 1, 2017 Dec 31, 2017

MADRIGAL PHARMACEUTICALS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -57.5 +162 +73.8% Jan 1, 2024 Dec 31, 2024
2023 -219 +50.8 +18.8% Jan 1, 2023 Dec 31, 2023
2022 -270 -170 -169% Jan 1, 2022 Dec 31, 2022
2021 -101 -36.2 -56.4% Jan 1, 2021 Dec 31, 2021
2020 -64.3 -45.5 -241% Jan 1, 2020 Dec 31, 2020
2019 -18.8 -10.8 -133% Jan 1, 2019 Dec 31, 2019
2018 -8.09 +29.4 +78.4% Jan 1, 2018 Dec 31, 2018
2017 -37.5 +28.6 +43.3% Jan 1, 2017 Dec 31, 2017
2016 -66 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.